GlassScriptPhysician profile
Abdul Samad Hashimi
NPI 1588873715
$175,034.48
in general payments reported to CMS, 2019-2025
10 companies · $21K in 2025
The $21K reported for 2025 was more than what 94% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $13K · 2021: $13K · 2022: $31K · 2023: $25K · 2024: $40K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $66K · Travel and Lodging: $12K · Food and Beverage: $7,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $66,000.00 |
| Travel and Lodging | $11,922.59 |
| Food and Beverage | $7,114.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $172,564.14 | 2019-2025 | Da Vinci Surgical System |
| Xvivo Perfusion INC. | $934.30 | 2024 | Xvivo Perfusion System (Xps) |
| Paragonix Technologies, INC. | $439.40 | 2024 | Lungguard, Baroguard, Pancreaspak |
| Abbott Laboratories | $323.81 | 2023-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $306.67 | 2021-2025 | |
| Davol INC. | $256.89 | 2023 | Progel Applicator Spray Tips, Phasix Mesh |
| United Therapeutics Corporation | $78.71 | 2025 | Steen Solution |
| Medtronic, INC. | $62.48 | 2023 | Gi Genius |
| Atricure, INC. | $43.28 | 2022 | |
| Stryker Corporation | $24.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Samad Hashimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.